BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17031686)

  • 1. Seizures as an adverse drug reaction after therapeutic dose of vincristine.
    Mahapatra M; Kumar R; Choudhry VP
    Ann Hematol; 2007 Feb; 86(2):153-4. PubMed ID: 17031686
    [No Abstract]   [Full Text] [Related]  

  • 2. Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia.
    Bacon LC; Barnett MJ; Abou Mourad YR
    Ann Hematol; 2012 Jun; 91(6):971-2. PubMed ID: 21976108
    [No Abstract]   [Full Text] [Related]  

  • 3. Bilateral vocal cord paralysis following treatment with vincristine.
    Naithani R; Dolai TK; Kumar R
    Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral vocal fold paralysis following treatment with vincristine.
    Praveen CV; De Lord CF
    J Laryngol Otol; 2006 May; 120(5):423. PubMed ID: 16696885
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
    Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
    Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.
    Riga M; Korres S; Psarommatis I; Varvutsi M; Giotakis I; Papadas T; Ferekidis E; Apostolopoulos N
    Otol Neurotol; 2007 Feb; 28(2):208-12. PubMed ID: 17255889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Harnicar S; Adel N; Jurcic J
    J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inappropriate ADH syndrome and other toxic effects in the course of childhood ALL treated with vincristine].
    Indiano JM; González A; Oria de Rueda O; Sánchez E
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():155-6. PubMed ID: 3214029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Encephalopathy appearing during treatment with vincristine. Anatomo-clinical case].
    Rosemberg S
    Arch Fr Pediatr; 1974 Apr; 31(4):391-8. PubMed ID: 4848646
    [No Abstract]   [Full Text] [Related]  

  • 10. Vincristine-induced bilateral vocal cord paralysis in children.
    Ahmed A; Williams D; Nicholson J
    Pediatr Blood Cancer; 2007 Feb; 48(2):248. PubMed ID: 16609949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isolated unilateral cranial nerve palsy during childhood acute lymphoblastic leukemia treatment: What does it mean?].
    Saumet L; Haouy S; Daien V; Hillaire-Buys D; Roessler J; Sirvent N
    Arch Pediatr; 2016 Apr; 23(4):415-6. PubMed ID: 26968305
    [No Abstract]   [Full Text] [Related]  

  • 12. A new formulation of vincristine for acute lymphoblastic leukemia.
    Heffner L
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):314-6. PubMed ID: 21558991
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral convulsions and acute psychosyndrome following vincristine therapy].
    Von Mittler U; Fischer HU; Schütze I; Jaenecke J
    Kinderarztl Prax; 1974 Sep; 42(9):403-7. PubMed ID: 4459498
    [No Abstract]   [Full Text] [Related]  

  • 14. Vincristine induced unilateral ptosis.
    Dejan S; Dragana B; Ivana P; Borivoje B; Marko P
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):463. PubMed ID: 19648799
    [No Abstract]   [Full Text] [Related]  

  • 15. Vincristine-itraconazole interaction: cause for increasing concern.
    Sathiapalan RK; Al-Nasser A; El-Solh H; Al-Mohsen I; Al-Jumaah S
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):591. PubMed ID: 12368705
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbone PP, Bono V, Frei E III, Brindley CO. Clinical studies with vincristine. Blood. 1963;21(5):640-647.
    Blood; 2016 Jun; 127(24):2941. PubMed ID: 27313320
    [No Abstract]   [Full Text] [Related]  

  • 17. Vincristine pharmacokinetics in children with Down syndrome.
    Lönnerholm G; Frost BM; Söderhäll S; de Graaf SS
    Pediatr Blood Cancer; 2009 Jan; 52(1):123-5. PubMed ID: 18615507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal myeloencephalopathy due to intrathecal vincristine administration.
    al Fawaz IM
    Ann Trop Paediatr; 1992; 12(3):339-42. PubMed ID: 1280054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
    Krappmann P; Paulides M; Stöhr W; Ittner E; Plattig B; Nickel P; Lackner H; Schrappe M; Janka G; Beck JD; Langer T
    Pediatr Hematol Oncol; 2007 Mar; 24(2):101-9. PubMed ID: 17454775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating children with acute lymphoblastic leukemia and Down syndrome: pharmacokinetics provides insight into vincristine therapy.
    Stewart CF
    Pediatr Blood Cancer; 2009 Jan; 52(1):1-2. PubMed ID: 18816806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.